The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• The tumor microenvironment (TME) in ovarian cancer (OC) is highly complex.
• Dysfunctional vasculature in OC leads to poor perfusion, hypoxia, and increased interstitial fluid pressure (IFP).
• These conditions impede therapeutic agent delivery into the tumor.

Purpose of the Study:

• To review the components of the OC TME.
• To discuss how TME characteristics inhibit therapeutic efficacy.
• To explore strategies for overcoming TME-mediated inhibition.

Main Methods:

• Literature review of studies on ovarian cancer tumor microenvironment.
• Analysis of the roles of vascular dysfunction and immunosuppressive cells.
• Examination of therapeutic strategies targeting the TME.

Main Results:

• OC TME exhibits rapid, dysfunctional angiogenesis contributing to hypoxia and high IFP.
• Key immunosuppressive cells include myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), regulatory T cells (Tregs), and cancer-associated fibroblasts (CAFs).
• These cellular and vascular components create an immunosuppressive milieu that limits immunotherapy (e.g., immune checkpoint inhibitors) success.

Conclusions:

• The complex OC TME, characterized by vascular abnormalities and immunosuppressive cells, presents significant barriers to effective cancer treatment.
• Strategies aimed at normalizing vasculature and modulating the immune suppressive TME are crucial for improving therapeutic outcomes in ovarian cancer.
• Further research into TME-targeting therapies is warranted to enhance treatment efficacy.